Befejeződött1. fázis
A Phase I Study of BMS-986497 alone or in combination with Azacitidine (Aza) and Azacitidine plus Venetoclax (AZA+VEN) in relapsed or refractory (R/R) AML or MDS
Key facts
- Where
- Marseille, Paris és Toulouse Cedex 9, FranciaországSee the 3 sites
- Phase
- 1. fázis
Where in Franciaország
- Institut Paoli-CalmettesMarseille, FranciaországNo longer taking part
- Assistance Publique Hopitaux de ParisParis, FranciaországNo longer taking part
- Oncopole Claudius RegaudToulouse Cedex 9, FranciaországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Bristol-Myers Squibb Services Unlimited Company
- Trial code
- EU 2024-519537-29-00
- Record updated
- 2026. augusztus 7.